Short communicationLanguage assessment in Wada test: Comparison of METHOHEXITAL (cas 18652-93-2) and amobarbital
-
Add time:09/27/2019 Source:sciencedirect.com
IntroductionMETHOHEXITAL (cas 18652-93-2) has replaced amobarbital during Wada testing at many centers. The objective of our study was to compare the use of methohexital and amobarbital during Wada testing regarding language and memory lateralization quotients as well as speech arrest times.
We also recommend Trading Suppliers and Manufacturers of METHOHEXITAL (cas 18652-93-2). Pls Click Website Link as below: cas 18652-93-2 suppliers
Prev:Comparison of METHOHEXITAL (cas 18652-93-2) and etomidate as anesthetic agents for electroconvulsive therapy in affective and psychotic disorders
Next:Seizures during intracarotid METHOHEXITAL (cas 18652-93-2) and amobarbital testing) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Seizures during intracarotid METHOHEXITAL (cas 18652-93-2) and amobarbital testing10/01/2019
- Comparison of METHOHEXITAL (cas 18652-93-2) and etomidate as anesthetic agents for electroconvulsive therapy in affective and psychotic disorders09/26/2019
- Original ContributionEvaluation of METHOHEXITAL (cas 18652-93-2) as an alternative to propofol in a high volume outpatient pediatric sedation service09/25/2019
- Case ReportPositive pharmacologic provocative testing with METHOHEXITAL (cas 18652-93-2) during cerebral arteriovenous malformation embolization09/24/2019
- METHOHEXITAL (cas 18652-93-2)☆09/10/2019
- Clinical studySuperselective METHOHEXITAL (cas 18652-93-2) challenge prior to intracranial endovascular embolization☆09/09/2019
